Adzymes and uses thereof

Details for Australian Patent Application No. 2003262937 (hide)

Owner Bristol-Myers Squibb Company

Inventors Dasgupta, Ruchira; Wong, Gordon G.; Afeyan, Noubar B.; Baynes, Brian; Lee, Frank D.

Agent Griffith Hack

Pub. Number AU-B-2003262937

PCT Number PCT/US03/26937

PCT Pub. Number WO2004/019878

Priority 60/423,754 05.11.02 US; 60/406,517 27.08.02 US; 60/430,001 27.11.02 US

Filing date 27 August 2003

Wipo publication date 19 March 2004

Acceptance publication date 7 May 2009

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/43 (2006.01) Medicinal preparations containing peptides - Enzymes

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C12N 9/50 (2006.01) Enzymes, e.g. ligases (6.) - Proteinases

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12P 21/04 (2006.01) Preparation of peptides or proteins - Cyclic or bridged peptides or polypeptides, e.g. bacitracin

Event Publications

11 December 2003 Complete Application Filed

  Priority application(s): 60/423,754 05.11.02 US; 60/406,517 27.08.02 US; 60/430,001 27.11.02 US

6 May 2004 Application Open to Public Inspection

  Published as AU-B-2003262937

9 June 2005 Amendment Made

  The nature of the amendment is: Delete the co-applicant Afeyan, Noubar B.

26 April 2007 Change of Name(s) of Applicant(s), Section 104

  Compund Therapeutics, Inc. The name of the applicant has been changed to Adnexus Therapeutics, Inc.

8 January 2009 Assignment before Grant

  Adnexus Therapeutics, Inc. The application has been assigned to Bristol-Myers Squibb Company

7 May 2009 Application Accepted

  Published as AU-B-2003262937

3 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003262938-EMBOLIC PROTECTION DEVICE

2003262936-NOS-2 AND GLAUCOMA